Pharma-Bio Serv (OTCMKTS:PBSV) Stock Crosses Below Two Hundred Day Moving Average of $0.91

Pharma-Bio Serv, Inc. (OTCMKTS:PBSVGet Free Report)’s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.91 and traded as low as $0.74. Pharma-Bio Serv shares last traded at $0.74, with a volume of 5,317 shares trading hands.

Pharma-Bio Serv Price Performance

The stock has a fifty day moving average of $0.85 and a two-hundred day moving average of $0.91. The stock has a market cap of $16.88 million, a price-to-earnings ratio of 24.50 and a beta of 0.51.

Pharma-Bio Serv (OTCMKTS:PBSVGet Free Report) last announced its quarterly earnings results on Monday, March 18th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.03). Pharma-Bio Serv had a net margin of 4.05% and a return on equity of 3.95%. The company had revenue of $2.38 million during the quarter, compared to analysts’ expectations of $5.00 million. On average, research analysts expect that Pharma-Bio Serv, Inc. will post 0.08 EPS for the current year.

Pharma-Bio Serv Company Profile

(Get Free Report)

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.

Featured Stories

Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.